Effects of Polyphenols on P-Glycoprotein (ABCB1) Activity
Open Access
- 2 December 2021
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (12) , 2062
Abstract
P-glycoprotein (Pgp, ABCB1) is a member of one of the largest families of active transporter proteins called ABC transporters. Thanks to its expression in tissues with barrier functions and its broad substrate spectrum, it is an important determinant of the absorption, metabolism and excretion of many drugs. Pgp and/or some other drug transporting ABC proteins (e.g., ABCG2, MRP1) are overexpressed in nearly all cancers and cancer stem cells by which cancer cells become resistant against many drugs. Thus, Pgp inhibition might be a strategy for fighting against drug-resistant cancer cells. Previous studies have shown that certain polyphenols interact with human Pgp. We tested the effect of 15 polyphenols of sour cherry origin on the basal and verapamil-stimulated ATPase activity of Pgp, calcein-AM and daunorubicin transport as well as on the conformation of Pgp using the conformation sensitive UIC2 mAb. We found that quercetin, quercetin-3-glucoside, narcissoside and ellagic acid inhibited the ATPase activity of Pgp and increased the accumulation of calcein and daunorubicin by Pgp-positive cells. Cyanidin-3O-sophoroside, catechin, naringenin, kuromanin and caffeic acid increased the ATPase activity of Pgp, while they had only a weaker effect on the intracellular accumulation of fluorescent Pgp substrates. Several tested polyphenols including epicatechin, trans-ferulic acid, oenin, malvin and chlorogenic acid were ineffective in all assays applied. Interestingly, catechin and epicatechin behave differently, although they are stereoisomers. We also investigated the effect of quercetin, naringenin and ellagic acid added in combination with verapamil on the transport activity of Pgp. In these experiments, we found that the transport inhibitory effect of the tested polyphenols and verapamil was additive or synergistic. Generally, our data demonstrate diverse interactions of the tested polyphenols with Pgp. Our results also call attention to the potential risks of drug–drug interactions (DDIs) associated with the consumption of dietary polyphenols concurrently with chemotherapy treatment involving Pgp substrate/inhibitor drugs.Keywords
Funding Information
- Nemzeti Kutatási és Technológiai Hivatal (K124815)
- GINOP (GINOP-2.2.1-15-2017-00079)
This publication has 61 references indexed in Scilit:
- Imaging of Cyclosporine Inhibition of P-Glycoprotein Activity Using 11C-Verapamil in the Brain: Studies of Healthy HumansJournal of Nuclear Medicine, 2009
- Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug BindingScience, 2009
- Plant Polyphenols as Dietary Antioxidants in Human Health and DiseaseOxidative Medicine and Cellular Longevity, 2009
- Use of fluorescence to determine the effects of cholesterol on lipid behavior in sphingomyelin liposomes and erythrocyte membranesJournal of Lipid Research, 2008
- Targeted therapy for cancer stem cells: the patched pathway and ABC transportersOncogene, 2007
- Flavonoid–drug interactions: Effects of flavonoids on ABC transportersLife Sciences, 2006
- Tumour stem cells and drug resistanceNature Reviews Cancer, 2005
- Effects of grapefruit juice on the multidrug transporter P-glycoprotein in the human proximal tubular cell line HK-2Life Sciences, 2004
- Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodiesBiochemical and Biophysical Research Communications, 2004
- Binding properties of monoclonal antibodies recognizing external epitopes of the human MDR1 P‐glycoproteinInternational Journal of Cancer, 1993